Basic Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jun 26, 2021; 9(18): 4542-4552
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4542
Figure 4
Figure 4 Tetramethylpyrazine inhibits colon cancer cell proliferation by inhibiting S phase synthesis. A: Tetramethylpyrazine (TMP) treatment increased the proportion of cells in the G0/G1 phase, whereas it decreased the proportion of cells in the S phase; B: The percentage of G1 phase cells significantly increased in cells treated with TMP at 600 µg/mL for 24 h. TMP: Tetramethylpyrazine.